• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[极低出生体重儿新生儿重症监护项目的有效性评估。表面活性剂给药的影响]

[Effectiveness assessment of a neonatal intensive care program for very low birth weight infants. Impact of surfactant administration].

作者信息

Fustiñana Carlos A, Izbizky Gustavo, Rodríguez Diana, Mariani Gonzalo, Ceriani Cernadas José M

机构信息

Servicio de Neonatología, Departamento de Pediatría, Hospital Italiano, Buenos Aires.

出版信息

Arch Argent Pediatr. 2009 Feb;107(1):9-15. doi: 10.1590/S0325-00752009000100005.

DOI:10.1590/S0325-00752009000100005
PMID:19350138
Abstract

INTRODUCTION

Although many therapeutic interventions have proven efficacy through randomized control trials (RCT) with extensive use in Neonatal Intensive Care Units (NICU) for Very Low Birth Weight Infants (VLBWI), doubts remain about its overall effectiveness.

OBJECTIVE

To determine changes in the effectiveness of NICU practices on VLBWI over 14 years in the quality of neonatal survival in a General Hospital, with emphasis in the change in reanimation practices by the introduction of the spread use of surfactant.

METHODS

We included all consecutive VLBWI admitted in our NICU during a period of 14 years: 1989-1992 (n= 145); 1993-2002 (n= 342). All survivors were included in our follow-up program; 80% and 85% were available for assessment at two years of corrected age. The patients were assigned to 4 groups by weight in 250 g categories, between 500 and 1500 g.

OUTCOME MEASURES

Survival and adjusted quality of survival (QS). The QS was expressed in life-years gained. We create categories for the estimation of disabilities. We also analyzed time of NICU stay by weight and mortality categories during the 2 periods.

RESULTS

The survival rate improved significantly between the 2 periods (23%) from 52% to 75%. The actuarial survival showed a significant increase in all weight groups (p <0.001), especially between 500-749 g (4% vs. 33%). The life-years gained showed differences in the BW <750 g (p <0.002, 3.6 vs. 23.4) y 750-999 g (p <0.001, 22.3 vs. 48); no differences were found in the others groups. The time of stay showed an increase of 30 days in the <750 g group (p <0.01) and decreased 8 days in the> or =1250 g group (p <0.01).

CONCLUSION

The effectiveness of neonatal intensive care for VLBWI improved in the period 1993-2002, after surfactant introduction, especially in the group <1000 g.

摘要

引言

尽管许多治疗干预措施已通过随机对照试验(RCT)证明有效,并在新生儿重症监护病房(NICU)中广泛用于极低出生体重儿(VLBWI),但其总体有效性仍存在疑问。

目的

确定一家综合医院14年来NICU对VLBWI的治疗措施在新生儿生存质量方面的有效性变化,重点关注因广泛使用表面活性剂而导致的复苏措施变化。

方法

我们纳入了14年间在我们NICU收治的所有连续的VLBWI:1989 - 1992年(n = 145);1993 - 2002年(n = 342)。所有幸存者均纳入我们的随访计划;校正年龄2岁时分别有80%和85%的患者可进行评估。根据体重以250 g为类别将患者分为4组,体重在500至1500 g之间。

观察指标

生存率和校正后的生存质量(QS)。QS以获得的生命年数表示。我们创建了残疾评估类别。我们还分析了这两个时期按体重和死亡率类别划分的NICU住院时间。

结果

两个时期之间的生存率显著提高(23%),从52%提高到75%。精算生存率在所有体重组中均显著增加(p <0.001),尤其是在500 - 749 g组(4%对33%)。获得的生命年数在体重<750 g组(p <0.002,3.6对23.4)和750 - 999 g组(p <0.001,22.3对48)存在差异;其他组未发现差异。住院时间在<750 g组增加了30天(p <0.01),在≥1250 g组减少了8天(p <0.01)。

结论

在1993 - 2002年期间,引入表面活性剂后,NICU对VLBWI的治疗有效性得到改善,尤其是在<1000 g组。

相似文献

1
[Effectiveness assessment of a neonatal intensive care program for very low birth weight infants. Impact of surfactant administration].[极低出生体重儿新生儿重症监护项目的有效性评估。表面活性剂给药的影响]
Arch Argent Pediatr. 2009 Feb;107(1):9-15. doi: 10.1590/S0325-00752009000100005.
2
Economic outcome for intensive care of infants of birthweight 500-999 g born in Victoria in the post surfactant era. The Victorian Infant Collaborative Study Group.后表面活性剂时代维多利亚州出生体重500 - 999克婴儿重症监护的经济结果。维多利亚州婴儿协作研究小组。
J Paediatr Child Health. 1997 Jun;33(3):202-8.
3
Improvement of short- and long-term outcomes for very low birth weight infants: Edmonton NIDCAP trial.极低出生体重儿短期和长期预后的改善:埃德蒙顿新生儿个体化发育护理与评估计划试验
Pediatrics. 2009 Oct;124(4):1009-20. doi: 10.1542/peds.2008-3808. Epub 2009 Sep 28.
4
Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. The Members of the National Institute of Child Health and Human Development Neonatal Research Network.与表面活性剂疗法引入相关的死亡率降低:对出生体重601至1300克新生儿的观察性研究。美国国立儿童健康与人类发展研究所新生儿研究网络成员。
Pediatrics. 1993 Aug;92(2):191-6.
5
[The combined effect of prenatal steroid prophylaxis, neonatal surfactant therapy and reduction of risk of complications from respiratory life support on survival rate of very low birthweight infants].[产前类固醇预防、新生儿表面活性剂治疗以及降低呼吸支持并发症风险对极低出生体重儿存活率的综合影响]
Orv Hetil. 2004 Jun 6;145(23):1227-32.
6
Interneonatal intensive care unit variation in growth rates and feeding practices in healthy moderately premature infants.健康中度早产儿在新生儿重症监护病房的生长速率及喂养方式差异
J Perinatol. 2005 Jul;25(7):478-85. doi: 10.1038/sj.jp.7211302.
7
Survival of the very-low-birth-weight infants after cardiopulmonary resuscitation in neonatal intensive care unit.新生儿重症监护病房极低出生体重儿心肺复苏后的存活情况。
J Perinatol. 2004 May;24(5):279-83. doi: 10.1038/sj.jp.7211054.
8
Drug utilisation in very preterm infants: any changes during the past decade?极早产儿的药物使用情况:过去十年有何变化?
Klin Padiatr. 2008 Jul-Aug;220(4):238-42. doi: 10.1055/s-2008-1046786. Epub 2008 Apr 9.
9
Early NICU discharge of very low birth weight infants: a critical review and analysis.极低出生体重儿早期从新生儿重症监护病房出院:一项批判性综述与分析。
Semin Neonatol. 2003 Apr;8(2):95-115. doi: 10.1016/S1084-2756(02)00219-1.
10
Survival rates of extremely preterm infants (gestational age <26 weeks) in Switzerland: impact of the Swiss guidelines for the care of infants born at the limit of viability.瑞士极早产儿(胎龄<26周)的存活率:瑞士关于出生时处于存活极限的婴儿护理指南的影响。
Arch Dis Child Fetal Neonatal Ed. 2009 Nov;94(6):F407-13. doi: 10.1136/adc.2008.154567. Epub 2009 Apr 8.

引用本文的文献

1
Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.中低收入国家中使用表面活性剂替代疗法治疗早产新生儿呼吸窘迫综合征的疗效和安全性:一项系统评价。
J Perinatol. 2016 May;36 Suppl 1(Suppl 1):S36-48. doi: 10.1038/jp.2016.31.